ArticleBMC infectious diseases2026
Antibiotic use appropriateness and its determinant factors among pediatric pneumonia patients in selected comprehensive specialized hospitals in Northwest Amhara, 2024: a prospective follow-up study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionProper use of antibiotics is the gold standard for treating bacterial pneumonia. Inappropriate prescribing leads to poor clinical outcomes and accelerates antibiotic resistance.
objectivesThis study aimed to assess the appropriateness of antibiotic use and identify its determinants in pediatric pneumonia patients in selected hospitals in Northwest Amhara in 2024.
methodsThis prospective multicenter study was conducted from June to September 2024 at three specialized hospitals in Northwest Ethiopia (Gondar, Debre Markos, and Bahir Dar). Data regarding diagnostic methods, pneumonia classification, and antibiotic regimens were extracted from the medical records of pediatric patients using a validated, structured checklist. The appropriateness of antibiotic use was evaluated against the 2021 Ethiopian National Standard Treatment Guideline and Infectious Diseases Society of America (IDSA) guidelines based on drug selection, dosage, frequency, and duration. Statistical analysis was performed using SPSS version 26. Multivariable logistic regression was employed to identify independent determinants of inappropriate antibiotic use, with statistical significance defined as P < 0.05.
resultAmong the 360 included patients (median age 1.5 years; 58.9% male), the majority (74.7%) were aged under five years, and 88.9% were diagnosed with Community-Acquired Pneumonia (CAP). Ceftriaxone was the most commonly prescribed antibiotic overall (38.1%). The prevalence of inappropriate antibiotic use was 38.3% (95% CI: 33.3–43.6%), with incorrect drug selection (42.9%) being the primary reason for inappropriateness. Independent predictors of inappropriate antibiotic use were prescriptions by pediatricians (AOR = 5.008, 95% CI: 1.228–20.425; p = 0.025), pediatric residents (AOR = 4.076, 95% CI: 2.492–6.667; p < 0.001), and the presence of comorbidity (AOR = 1.717, 95% CI: 1.062–2.777; p = 0.027).
conclusionInappropriate antibiotic use remains a major concern in managing pediatric pneumonia, contributing to poor clinical outcomes. Prescriptions by pediatricians and pediatric residents, and comorbidity were associated with inappropriate antibiotic use, and hence practitioners should never disregard these factors to prioritize those cases coming with them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.